• AG-490 (Tyrphostin B42): Dissecting JAK2/STAT6 in Tumor Immu

  2026-07-17

  Explore how AG-490 (Tyrphostin B42) enables precise inhibition of JAK2/STAT6 signaling, with unique insights into macrophage polarization and tumor microenvironment modulation. This article offers an advanced, scientifically grounded perspective for cancer research applications.

• METTL17-Mediated Mitochondrial Control of Ferroptosis in CRC

  2026-07-17

  The referenced study uncovers a novel role for the mitochondrial methyltransferase METTL17 in coordinating ferroptosis resistance and tumorigenesis in colorectal cancer (CRC). By regulating mitochondrial RNA methylation and translation, METTL17 emerges as a key mitochondrial defense node and a promising therapeutic target for sensitizing CRC cells to ferroptosis-based therapies.

• Dacomitinib (PF-00299804): Protocols for Pan-HER & Ferroptos

  2026-07-16

  Dacomitinib (PF-00299804) uniquely enables irreversible pan-HER inhibition, supporting advanced workflows in resistant cancer models. Recent mitochondrial ferroptosis insights unlock new combinatorial assay strategies, positioning Dacomitinib as a versatile tool for both mechanistic and translational oncology research.

• Dacomitinib (PF-00299804): Potent Pan-HER Inhibitor for Canc

  2026-07-16

  Dacomitinib (PF-00299804) is a highly selective, irreversible pan-HER inhibitor that targets EGFR, HER2, and HER4 with sub-100 nM potency, inducing apoptosis and sustained cell cycle arrest in resistant cancer models. Evidence demonstrates its efficacy in both in vitro and in vivo systems, especially in non-small-cell lung carcinoma and HER2-amplified breast cancer research.

• Calcitriol in Bench Research: Protocol Innovations and Troub

  2026-07-15

  Calcitriol, the active metabolite of vitamin D3, drives advanced research in bone, immune, and cellular signaling contexts. This guide delivers actionable protocol insights, troubleshooting strategies, and highlights the latest workflow innovations for leveraging Calcitriol in translational and mechanistic studies.

• CHI3L1 Inhibition Restores Amyloid Clearance in Alzheimer’s

  2026-07-15

  A recent study demonstrates that selective inhibition of CHI3L1 with Compound Z17 (CHI3L1-IN-5) restores amyloid-beta clearance and lysosomal function in human astrocytes, providing mechanistic insight into dual targeting of neuroinflammation and protein aggregation in Alzheimer’s disease. These findings highlight the therapeutic promise of CHI3L1 pathway inhibition for addressing both inflammatory and clearance deficits in neurodegenerative research.

• PP 2 (AG 1879): Dissecting Src-FAK-ROCK Pathways in Cell Mor

  2026-07-14

  Explore how PP 2 (AG 1879) enables precise dissection of Src-mediated cytoskeletal remodeling in cellular models. This article uniquely bridges advanced mechanistic insight from recent research with protocol applications, making it an essential resource for cancer research and cell signaling studies.

• HyperScript™ Reverse Transcriptase in High-Fidelity cDNA Syn

  2026-07-14

  HyperScript™ Reverse Transcriptase empowers robust cDNA synthesis—even with structured or low-abundance RNA—by combining high thermal stability with reduced RNase H activity. Its performance streamlines workflows for quantitative gene expression, as demonstrated in advanced animal welfare transcriptomic studies.

• X-press Tag Peptide: Reproducible Purification for Cell Assa

  2026-07-13

  This article explores how the X-press Tag Peptide (SKU A6010) provides robust, reproducible solutions for protein purification and detection in cell viability, proliferation, and cytotoxicity assays. Scenario-driven Q&A blocks address real laboratory challenges, offering data-backed guidance for protocol design, vendor selection, and assay optimization.

• I-BET-762 as a BET Inhibitor: Protocols and Advanced Applica

  2026-07-13

  I-BET-762, a potent and selective BET inhibitor, empowers researchers to dissect transcriptional regulation and ferroptosis with high reproducibility. This guide distills applied workflows, troubleshooting strategies, and translational insights—bridging anti-inflammatory, cancer, and epigenetic research using APExBIO’s trusted I-BET-762.

• pH-Dependent Solubility of LEE011 Succinate: Implications fo

  2026-07-12

  This study evaluates the impact of acid-reducing agents on the solubility and absorption of ribociclib succinate (LEE011), a selective CDK4/6 inhibitor for cancer research. Using a Quality by Design (QbD) analytical approach, the findings indicate that co-administration with acid-reducing agents does not significantly affect drug solubility or absorption, providing practical guidance for experimental and clinical workflows.

• Early Life Adversity Disrupts Innate Defensive Behavior via

  2026-07-10

  This study demonstrates that early life adversity (ELA) impairs visually evoked innate defensive responses in mice by reducing oxytocin receptor expression in the superior colliculus. The work establishes a mechanistic link between early stress, oxytocin signaling, and innate fear processing, offering new insight for neuropsychiatric research.

• Optimizing mRNA Delivery: Advanced Insights Into EZ Cap™ Cy5

  2026-07-09

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), a Cy5-labeled mRNA, enhances precision in gene delivery and translation assays. This article uniquely bridges molecular mechanisms, reference-driven innovations, and real-world workflow decisions for advanced cell analysis.

• GTP Solution in mRNA Synthesis: Protocols and Tumor Suppress

  2026-07-09

  GTP Solution (100 mM) enables high-purity, contamination-free mRNA synthesis critical for advanced gene therapy and tumor suppressor research. This guide bridges bench protocols with clinical innovations, spotlighting troubleshooting strategies and workflow enhancements for sensitive in vitro transcription and lipid nanoparticle platforms.

• S Tag Peptide: Technical Guidance for Protein Tagging Workfl

  2026-07-08

  The S Tag Peptide is a 15-amino acid fusion tag designed to improve protein solubility and facilitate sensitive detection or purification in recombinant protein workflows. It is best applied in systems where short-term aqueous storage and high solubility are required, but should be avoided if ethanol solubility or long-term solution stability is necessary.

16190 records 1/1080 page Next 12345 下5页 Last page